Teclison
Ray Lee is a recognized leader in medical oncology with over 20 years of experience as a university faculty and clinical development leader at Merck and Roche as Senior Director. He has extensive experience in designing large-scale clinical development plans, and successfully leading teams for NDA filing and application of Breakthrough Therapy Designation. He is a patent inventor and board-certified medical oncologist in the US. He had a medical oncology fellowship at the University of Washington, and an Internal Medicine residency at Duke University Medical Center. He received his PhD in Biochemistry from Duke University and MD from National Taiwan University.
This person is not in any offices
Teclison
Teclison was founded with the vision of assembling leading scientists, advisors, and other leaders with significant pharmaceutical expertise to develop groundbreaking therapies for cancer. The company specializes in the development of innovative cancer medicines which induce tumor necrosis and enhance anti-tumor immunity for long-term cancer remission.